Amgen confirmed Monday it will acquire rare disease giant Horizon Therapeutics for $26.4 billion.
Tag Archive for: Uplizna
And then there were two. Janssen (Johnson & Johnson) is no longer in the running to acquire rare disease player Horizon Therapeutics, the company announced Saturday.
